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This study determined the ability of an oral nutraceutical supplement to attenuate the
oxidative stress and inﬂammation that occurs in muscles and joints with repeated bouts of
high-intensity exercise in horses. The supplement, fed daily, was comprised of whole
dried mushrooms, golden ﬂaxseed, omega-3 fatty acids, plant-based enzymes, a melon-
concentrate powder, and Saccharomyces cerevisiae boulardii. Ten horses participated in a
partial cross-over design,with 7 horses completing the Control trial and 7 horses completing
the supplement trial. Blood and synovial ﬂuid samples (from the intercarpal joint) were
takenbefore, and at 1 and24hours after a standardized, repeatedhigh-intensityexercise test
thatwas performed before supplementation and on the 22nd dayof supplementation. At the
end of the supplement trial exercise resulted in reduced concentrations of plasmamarkers of
oxidative stress (decreased thiobarbituric acid reactive substances, with increased total
antioxidant status and increased superoxide dismutase activity); there was no effect on
plasmamarkers of muscle injury (creatine, creatine kinase, and aspartate aminotransferase)
or inﬂammation (PGE2, nitric oxide). Within synovial ﬂuid, there was a tendency for
increased superoxide dismutase activity, and decreased concentration of glycosaminogly-
cans. It is concluded that the supplement, when fed to horses as part of the normal diet for
23 days, was associated with reduced concentrations of markers of oxidative stress and
inﬂammation in muscle and synovial ﬂuid.
Crown Copyright  2016 Published by Elsevier Inc. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Historically, the main research focus on traditional
(non-nutraceutical) nutritional supplements for horses has
been on macronutrients (carbohydrates, fats, and protein
or amino acids), trace minerals and electrolytes for their
ability to improve health and performance. However,
despite seemingly optimizing these aspects of nutrition,
horses often do not appear to reach their genetic and/or
physiological potential. Recent research efforts are
increasingly directed towards examining the effects ofr, The Nutraceutical
dinger).
2016 Published by Elseviernutraceuticals or functional foods on health, wellness, and
physical and cognitive performance. These products are
typically single animal or plant components, or blends of
such components that are believed to exert wellness
beneﬁts that cannot be readily attributed to classical
nutrition. Nutraceutical products often comprise a vast
array of bioactive molecules that interact with numerous
biochemical and signaling pathways in virtually every cell
system within the body. The plant and animal parts
from which these nutraceutical products are derived
tend to have a long history of use in human and animal
folklore medicine. At the same time, we have a poor
understanding of these products because of their complex
nature and myriad interactions. Therefore, research using
such products is needed.Inc. This is an open access article under the CC BY-NC-ND license (http://
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ceutical supplements marketplace aimed at reducing the
negative effects of oxidative stress and inﬂammation that
occurs as a result of high-intensity exercise training. The
rationale is that excessive oxidative stress can result in an
exaggerated inﬂammatory response [1,2] and may be
detrimental to normal healing of affected tissues [2]. At the
same, it is recognized that inﬂammation is a normal part of
the tissue repair, and that normal adaptation to normal
stress (i.e., exercise training and competition) requires
controlled inﬂammation that allows repair to occur
without severe tissue destruction.
In horses, oxidative stress occurs during intense exercise
[3–5] and endurance exercise [6,7] and is often associated
with muscle membrane leakage. In animal studies,
strenuous exercise that results in muscle microtrauma
(ultrastructural damage) is characterized by leukocyte
inﬁltration and an inﬂammatory response resulting from
oxidative stress [1]. Part of the healing process to
microtrauma involves the inﬂammation that occurs in
response to the damage.
The present study tested the hypothesis that a nutra-
ceutical supplement comprised of ingredients that confer
antioxidative, anti-inﬂammatory, and immune-enhancing
effects will attenuate the severity of oxidative stress and
inﬂammation that occurs in skeletal muscle and joints as a
consequence of high-intensity exercise training. The
present study used a stress of repeatedw60 s gallop bouts
with 4–5 minutes of walking rest between gallops. The
supplement is comprised of mushrooms and yeast that
are rich in immune-enhancing 1/3 and 1/6 b-glucans
[8–13], a superoxide dismutase (SOD)–rich melon
concentrate [14], golden ﬂaxseed, and a microencapsulated
ﬁsh oil rich in omega-3 oils (minimum 28% by
weight including EPA and DHA) selected to confer
anti-inﬂammatory effects [15,16]. The product also is
comprised 20% by weight of a blend of nonanimal source
enzymes containing a combination of proteases, peptidase,
amylase, and lipase.Table 1
Characteristics of the horses that completed trials in the study.
Horse Treatment Initial, Final Mass, kg Sex Age
Sasha C 583 M 6
Lance C 498, 491
S 489, 466a
Stella S 511, 516 M 5
C 480, 493
Lilo S 585, 587 M 7
Rosie C 565, 566 M
Norman C 571, 582 G 9
S 586, 578
Lucus C 533, 535
S 530, 528
Dixi S 472, 474 M 6
C 467, 477
Snoopy S 597, 604 G 6
Daisy C 630, 629
Reese S 613, 610 M 5
Abbreviations: C, control; Dx, Dutch warmblood cross; G, gelding; M, mare; OH,
thoroughbred.
a Not completing the morning meal, but completed the afternoon meal.2. Materials and Methods
Ten privately owned healthy, adult horses of mixed
breed and gender participated in the study (Table 1).
Owners freely agreed for their horse(s) to participate and
signed an informed consent. Horses were outdoor stabled,
with access to large run-in shelters with free access to hay
and water at all times. The study was performed during the
fall of 2015 near Toronto, Canada. A horse health check and
lameness examinationwere performed on animals selected
for the study. Five of the horses had to be withdrawn from
the study: two due to lameness, two at the owner’s request,
and one due to negative behavior associated with the
arthrocentesis procedure. Therefore, ﬁve horses fully
completed both the placebo and supplement trials (double
crossover design), with two additional horses completing
either the placebo trial or the supplement trial. Animal care
and use procedures were approved by the Nutraceutical
Alliance Animal Care Committee in compliance with the
Animals for Research Act (Ontario) and the Canadian
Council on Animal Care guidelines.
Horses (Table 1) were fed twice daily (w7 am and w4
pm) an individually tailored ration designed to meet their
nutritional needs based on their work, body condition, and
nutritional analysis of forage. Horses had ad libitum access
to hay and water. The basal diet for Daisy, Stella, Lance, Lilo,
Sasha, Rosalie, and Snoopy was 250 g of a ration balancer
(Equilibrium Equilizer, Agribrands Purina, Woodstock, ON,
Canada) and 40-g trace mineralized salt (Canadian
Stockman, Sifto, Mississauga, ON, Canada). The basal diet
for Dixi, Lucus, Norman, and Reese was 1.5 kg of Happy
Horse pelleted feed ration (W-S Feeds, Tavistock, ON,
Canada), 1-kg beet pulp pellets (Sharp’s Feed Mills,
Guelph, ON, Canada), 700-g ground ﬂaxseed (Sharp’s
Feed Mills, Guelph, ON, Canada) and 75 g of trace
mineralized salt (Canadian Stockman, Sifto, Mississauga,
ON, Canada). The ingredients in Equilibrium Equalizer are
soy hulls, dehydrated alfalfa meal, soy oil, ﬂaxseed,
wheat shorts, lysine, vitamins, minerals, and ﬂavoring, y Breed Exercise Bouts Reason for Withdrawal
Dx 4 Lameness
Morgan 3
3
Px 3
3
OH 4
TB 4 Behavior
TB 4
4 Owner request
TB 4
4
TB 4
4 Owner request
Paint 3
TB 3
Dx 4 Lameness
Oldenburg Holsteiner cross; Px, Hafﬂinger pony cross; S, supplement; TB,
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lizer/). The ingredients in the trace mineralized salt are
sodium chloride (96.5% minimum), zinc 4,000 mg/kg,
iron 1,600 mg/kg, manganese 1,200 mg/kg, copper
330 mg/kg, iodine 100 mg/kg, and cobalt 40 mg/kg.
The ingredients of the Happy Horse pelleted feed
ration are wheat shorts, alfalfa meal, soy hulls, soy oil,
molasses, limestone F (pulverized), water (liquid
pellet conditioner), ﬁne salt, Pelltech (Borregaard
LignoTech, Sarpsborg, Norway), horse premix (2% by
weight vitamins and minerals), Novin toxin binder,
Santoquinddry (Novus), biotin 2,000 mg/kg of premix,
and vitamin E (500,000 IU/kg).
The supplement is a proprietary, dry powder/particulate
blend of mushrooms (proprietary; Equilabs, Wootton,
Northampton, UK), yeast (Saccharomyces cerevisiae strain
SB20; Lallemand Animal Nutrition, Milwaukee, WI), a
SOD-rich melon-concentrate (6.7% by weight; Lallemand
Animal Nutrition, Milwaukee, WI), powdered golden
ﬂaxseed (Pizzey Ingredients, Russell, MB, Canada), a
powdered microencapsulated ﬁsh oil rich in omega-3 fatty
acids (minimum 28% by weight including EPA and DHA;
Novotech, Ventura, CA), and a proprietary blend of
nonanimal source enzymes (20% by weight of proteases,
peptidase, amylase and lipase; Specialty Enzymes, Chino,
CA). Horses on the supplement trials received a
loading dose of 30 grams per day for 7 days, followed by
15 grams per day for the remainder of the supplementation
period.
Before the beginning of the 23-day supplementation
period, horses completed a standardized high-intensity
exercise test. Horses were ﬁtted with a heart rate monitor
with electrode placement underneath the saddle and girth
strap. Two or three horses were exercised together. Riders
mounted the horses at approximately 10 AM, and the
horses were warmed up for 20 minutes by walking,
trotting, and cantering. The test was performed on ﬁrm dirt
½-mile course. The test comprised three or four bouts of
½-mile gallop with a 4-minute walking rest between each
bout. The intensity, before and after supplementation test,
was standardized with respect to distance (1/2-mile laps),Fig. 1. Schematic overview of the pheart rate (greater than 190 bpm), and speed (based on
time required to complete ½-mile laps). The determination
for 3 or 4 bouts was on the basis of time required to
complete the ½-mile course: when the time required was
 10% slower than the fastest bout (typically the second
bout) then that was taken as the ﬁnal bout. Heart rates
were recorded at the end of each bout when the horse
crossed the ﬁnish line. At the end of the ﬁnal bout, horses
were walked for 30 minutes to cool out, hosed off with
water, and placed into a stall (w50 minutes after exercise)
before sampling blood and synovial ﬂuid from a sampling
fore limb intercarpal joint at 60 minutes after exercise.
An overview of the study protocol is shown in Fig. 1.
Every morning at w7 am, horses were fed their morning
meal (with or without supplement as appropriate for the
trial). On the morning (between 10 and 11 am) of the day
preceding the exercise test, the hair coat overlying the
blood and synovial ﬂuid sampling sites was clipped, the
sites aseptically prepared and jugular venous blood and
synovial ﬂuid samples were taken as described previously
[17]. On the morning of the test, horses were fed at 7 AM,
three hours before warm up for the exercise test. Ten
minutes before obtaining the 60-minute postexercise
samples, sites were aseptically prepared and jugular
venous blood and synovial ﬂuid sampled. The following
day, at 24 hours after exercise, the process was repeated.
Blood was collected into one EDTA-containing (for
complete blood count) and two heparin-containing
(for plasma biochemistry) 7-mL blood collection tubes
(Becton-Dickenson, Mississauga, ON). Synovial ﬂuid was
collected into a 7 mL, heparin-containing blood collection
tube. One blood sample and the synovial ﬂuid sample
collected in heparin-containing tubes were centrifuged for
15 minutes at 3,000 g to remove cells. The supernatant was
collected and split equally into two 1-mL cryovials.
These samples were stored at 20C until analyzed.
The two remaining blood collection tubes were analyzed
for CBC (Siemens Model Advia 2120) and chemistry
(Johnson & Johnson, Ortho Clinical Diagnostics Model 5.1
Fusion) by Nassagaweya Veterinary Laboratory Services
(Campbellville, ON, Canada).rotocol used for each horse.
Table 2
Synovial ﬂuid oxidative stress responses to high-intensity exercise in the Control and Supplement trials, comparing exercise responses and
presupplementation with postsupplementation time points.
Oxidative Stress Marker Trial Before Exercise 1 Hour After Exercise 24 Hours After Exercise
Presupplement
TAS (mM) Control 1.65  0.048 1.65  0.060 1.61  0.055
SOD activity (IU/mL) Control 223  11 226  15 212  13
TAS (nM) Supplement 1.83  0.184 1.67  0.285 1.74  0.235
SOD activity (IU/mL) Supplement 216  11 222  25 222  11
Postsupplement
TAS (mM) Controld 1.610  0.021 1.383  0.143d 1.636  0.033
SOD activity (IU/mL) Controlb 167  20 172  20a 186  9.8a
TAS (mM) Supplementd 1.63  0.023 1.62  0.090 1.72  0.121
SOD activity (IU/mL) Supplementc 182  12 202  6.7e 207  24e
a Signiﬁcantly different than time 0.
b Signiﬁcantly different than presupplementation within trial.
c Signiﬁcantly different than presupplementation trial.
d Tendency for difference from presupplementation within trial.
e Tendency for signiﬁcant difference from pre-exercise mean.
Table 3
Synovial ﬂuid markers of inﬂammation in response to high-intensity
exercise in the control and supplement trials, comparing exercise
responses and presupplementationwith postsupplementation time points.
Trial Before
Exercise
1 Hour After
Exercise
24 Hours After
Exercise
PGE2 (ng/L)
Precontrol 202.9  54.5 291.5  72.7 245.8  48.3
Postcontrol 368.5  72.3 417.0  72.7 311.7  69.9a
Presupplement 184.4  70.6 236.7  66.2 258.5  85.1
Postsupplement 356.7  73.9 349.0  51.8 236.5  41.2
NO (mM)
Precontrol 7.03  1.33 15.1  4.35 15.8  4.59
Postcontrol 8.90  0.71 43.8b  18.4 13.0  2.52
Presupplement 11.7  5.39 14.1  5.24 20.5  8.75
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hyaluronidase to improve assay precision [18], resulting in
1:2 dilution. This hyaluronidase-treated synovial ﬂuid was
assayed for PGE2 (DetectX Prostaglandin E2 Enzyme
Immunoassay Kit K051-H1, Arbor Assays), nitric oxide
(Griess Reagent Kit for Nitrite Determination, G-7921,
Molecular Probes), SOD activity (Superoxide Dismutase
Assay Kit 7500-100 K, Trevigen), and total antioxidant
status (TAS, Antioxidant Assay Kit 709001, Cayman Chem-
ical). Untreated synovial ﬂuid was used for measurement of
glycosaminoglycan (GAG) concentrations using themethod
of Chandrasekhar et al. [19]. All assays were performed in
duplicate. Plasma samples were analyzed in duplicate for
thiobarbituric acid reactive substances (Parameter thio-
barbituric acid reactive substances [TBARS] Assay KGE013,
R&D Systems), PGE2 (DetectX Prostaglandin E2 Enzyme
Immunoassay Kit K051-H1, Arbor Assays), nitric oxide
(Griess Reagent Kit for Nitrite Determination, G-7921,
Molecular Probes), SOD activity (Superoxide Dismutase
Assay Kit 7500-100 K, Trevigen), and TAS (Antioxidant
Assay Kit 709001, Cayman Chemical). All assays were
performed using 96 well plates, and absorbances detected
and recorded using a microplate plate reader (1420 Victor
2, Perkin Elmer; Fusion a, Perkin Elmer).
Datawere analyzedwith respect to presupplementation
versus postsupplementation, exercise time points, and trial
using a series of two-way analysis of variance (ANOVA).
Within trial or exercise trial effects were examined using
one-way repeated measures ANOVA. When a signiﬁcant
F-ratio was obtained the Holm–Sidak post hoc test was to
identify different means. Statistical signiﬁcance was
accepted at P  .05, and a statistical tendency was
designated as P > .05 and  .10. Tendencies (.05 < P  .10
weak evidence against the null hypothesis in favor of the
alternative) were also used to describe the data [20].Postsupplement 8.61  0.665 20.1  6.42 29.0  13.8
GAG (mg/L)
Precontrol 290.3  7.43 412.7  61.5 418.7  70.9
Postcontrol 342.5  50.1 817.1b  329.0 309.3  16.4
Presupplement 288.7  8.08 774.8  382.6 492.1  136.0
Postsupplement 302.3  7.14 411.2  92.1 474.0  143.4
a Signiﬁcantly different than mean at 1 hour after exercise.
b Tendency for signiﬁcant difference from pre-exercise mean.3. Results
3.1. Synovial Fluid Markers of Oxidative Stress
There was no signiﬁcant effect of exercise on intercarpal
joint synovial ﬂuid markers of oxidative stress (Table 2).There was an effect of trial duration on SOD activity, which
was lower at the end of the trial period before exercise with
both control and supplement trials. In the Control trial, TAS
tended (P ¼ .095) to be lower 1 hour after exercise at the
post-trial compared to pretrial. After 23 days of the
supplement, synovial ﬂuid SOD was higher than
presupplementation, and there was a tendency (P ¼ .10)
for increased SOD activity postexercise compared to
pre-exercise. TAS tended (P ¼ .059) to be higher at 1 hour
after exercise at the end of supplementation, compared to
control, which showed a decrease (P ¼ .10) at 1 hour
postexercise compared to pre-exercise. In the supplement
trial, compared to Control, SOD activity also tended
(P ¼ .076) to be greater at 1 and 24 hours postexercise
postsupplementation test.
3.2. Synovial Fluid Markers of inﬂammation
There was no signiﬁcant effect of exercise on synovial
ﬂuid markers of inﬂammation (Table 3). There was also no
effect of time or trial on synovial ﬂuid NO concentrations. In
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increased PGE2 in response to exercise (P¼ .073) and due to
trial duration (P ¼ .073). In the supplement trial, compared
to the control trial, high-intensity exercise did not result in
increased in PGE2 at either postexercise time point.
Inﬂammationwithin the joint can lead to degradation of
cartilage matrix resulting in release of GAGs. GAG was
signiﬁcantly increased at 1 hour postexercise in both
Control trial exercise tests, and in the pretrial exercise test
for the supplement (Fig. 2). In contrast, after 23 days of the
supplement, synovial ﬂuid GAG did not increase in
response to exercise and tended (P¼ .078) to be lower after
supplementation. In summary, there was a tendency for
attenuation of PGE2 concentrations after supplementation
and no evidence of increased synovial ﬂuid GAG, compared
to control and to supplement pretrial high-intensity
exercise tests.
3.3. Plasma Markers of Oxidative Stress
Within the Control trial there was no effect of exercise
or trial duration on TAS, SOD and TBARS (Fig. 3). Two-way
ANOVA comparing exercise and trial did not show any
signiﬁcant differences between control and supplement.
Within the supplement trial, there was no effect of
exercise on oxidative stress markers. However, 23 days of
supplementation resulted in signiﬁcant increases TAS and
SOD activity and a signiﬁcant decrease in TBARS (Fig. 3)
compared to presupplementation. SOD activity in both
trials was similar in the presupplementation test. In
contrast, at the end of the trial, SOD activity was greater in
the supplement trial than in the Control trial. In summary,
the supplement showed a signiﬁcant decrease in TBARS
associated with increased TAS and increased SOD activity.
3.4. Plasma Markers of Inﬂammation
There was a tendency (P ¼ .073) for increased plasma
PGE2 in response to exercise (Table 4). There was a
signiﬁcant decrease in plasma NO 1-hour after exercise
in the presupplementation Control trial. There was atendency (P ¼ .1) for reduced PGE2 after 23 days of
supplementation compared to the control trial. In
summary, because exercise did not produce profound effect
on markers of inﬂammation, despite evidence of oxidative
stress, it was unlikely that there would be effects of
supplementation.3.5. Plasma Markers of Skeletal Muscle Cellular Integrity
Exercise resulted in signiﬁcant increases in plasma
markers of muscle damage, both at 1 and 24 hours after
exercise (Table 5). In both Control trials signiﬁcant
Table 4
Plasma markers of inﬂammation in response to high-intensity exercise in
the control and supplement trials, comparing exercise responses and
presupplementation with postsupplementation time points.
Supplementation Before
Exercise
1 Hour After
Exercise
24 Hours After
Exercise
PGE2 (ng/L)
Precontrol 108.7  27.5 331.9  147.6 357.9  156.2
Postcontrol 147.6  21.6 440.7  213.8 495.5  246.7
Presupplement 223.0  72.6 258.8  77.7 232.1  76.6
postsupplement 184.3  53.9 337.7  140.9 330.2  159.2
NO (mM)
Precontrol 52.6  7.28 29.8  5.29a 51.0  7.89
postcontrol 58.3  8.32 49.3  5.38 58.2  6.88
presupplement 47.6  7.37 42.7  5.98 45.6  7.47
postsupplement 45.5  7.96 51.9  8.12 47.0  7.70
a Signiﬁcantly different than time 0 (pre-exercise).
Table 5
Plasma markers of skeletal muscle integrity in response to high-intensity
exercise in the control and supplement trials, comparing exercise
responses and presupplementationwith postsupplementation time points.
Presupplement
(n ¼ 8) and
Postsupplement
(n ¼ 7)
Before
Exercise
1 Hour After
Exercise
24 hours
After Exercise
CK (IU/L)
Precontrol 199.4  17.1 585.1  104.9a 452.4  92.5a
Postcontrol 258.3  44.2 698.6  76.9a 681.9  125.4a
Presupplement 228  21.9 469  90.8a 371  89.5
Postsupplement 275  28.5 641  176b 1445  721b
Creatine (mM)
Precontrol 121.8  14.1 147.1  10.8a 118.5  8.95
Postcontrol 113.3  6.27 149.3  5.71a 117.0  7.02
Presupplement 100  8.6 127  10.7a 107  9.9
Postsupplement 103 þ 7.8 141  9.1a 107  9.1
AST (IU/L)
Precontrol 382.6  26.8 387.5  21.7 459.4a  39.5
Postcontrol 342.7  21.8 401.6  42.2 524.9a  95.4
Presupplement 356  30 398  24 430b  58
Postsupplement 397  60 455  56 595  182
Alk P (IU/L)
Precontrol 171.9  14.0 203.0  16.1a 182.6  13.2
Postcontrol 157.0  17.3 187.7  11.2a 161.0  13.2
Presupplement 137  12.8 159  13.4a 146  13.5
Postsupplement 148  19.7 187  25.5a 152  23.3
GGT (IU/L)
Precontrol 29.7  3.06 27.9  1.61 25.9  2.10
Postcontrol 24.6  4.26 34.7  9.52 32.57  8.95
Presupplement 26.9  1.49 30.6  1.39a 27.1  2.06
Postsupplement 24.9  2.55 40.0  11.8 37.3  11.0
a Signiﬁcantly different than time 0 (preexercise).
b Tendency for mean to be different from time 0 (preexercise).
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transferase (AST) persisted to 24 hours postexercise. After
23 days of supplementation, there were no signiﬁcant
elevations on average, although one horse had an elevated
CK. There were no differences between the Control trials
and supplementation trials.
3.6. Other Blood Parameters
Typical exercise effects were observed with respect to
blood cells, white cell differentials, and red cell variables
(data not reported). Exercise effects also occurred with
plasma proteins, electrolytes, and other biochemical
variables (data not reported). These were expected exercise
responses. There were no effects of the supplement on
these parameters.
4. Discussion
This is the ﬁrst study to examine the effects of dietary
supplementation designed to have combined antioxidant,
anti-inﬂammatory, immune-enhancing product on sys-
temic and synovial ﬂuid oxidative stress and inﬂammation
markers in horses that have performed exercise of sufﬁ-
ciently high intensity to cause oxidative stress and
inﬂammation. This study showed that, compared to the
Control trial, 23 days of supplementation with the product
showed some evidence of decreased skeletal muscle injury
and decreased intercarpal joint GAG release. The absence of
effect of the supplement on red cells, white cells, and
plasma biochemistry showed no evidence of adverse
events to these blood systems and thus appeared safe over
the 23 day period of use.
4.1. Effects in Articulating Joints
The exercise test was chosen for its ability to result in
mild-to-moderate oxidative stress associated with mild-to-
moderate muscle injury and inﬂammation [21,22]. It was
also expected that this intensity of exercise would generate
a mild inﬂammatory response within limb articulating
joints, in agreement with previous research [23,24]. Excess
production of reactive oxygen species (ROS, such as
superoxide and hydrogen peroxide) within muscle or jointsdirectly contributes to the inﬂammation of these tissues
[21,25]. Oxidative stress and inﬂammation within joints is
manifest by decreased TAS, increased markers of
inﬂammation (PGE2, NO), and cartilage matrix components
(GAG) within synovial ﬂuid [17]. In the present study, there
was little evidence of oxidative stresswithin the intercarpal
joint, with only a moderate decrease in TAS at 1 hour after
exercise at the end of the Control trial (Table 2). The general
absence of effect of exercise on markers of oxidative stress
within the joint suggests that innate mechanisms for
handling oxygen free radicals were adequate, even
during the Control trial. It is of interest that in both the
Control and supplement trials that SOD activity was
reduced in the postsupplementation test compared to the
postsupplementation test (Table 2). There is no obvious
explanation for this result. Of greater interest, perhaps,
is the upregulation of SOD activity that occurred at
1 hour after exercise after 23 days of the supplement.
Determination of a cellular mechanism for this response
requires further study.
The mild-to-moderate oxidative stress and inﬂamma-
tion within limb joints resulting from strenuous exercise
can be attributed to the repeated, forceful impacts of the
hoof with the terrain resulting in ground reaction forces
travelling up the limb [26–28]. In addition, the repeated
and forceful extensions and ﬂexions around the joint
causes stress to all joint structures including the
synovial membrane and articular cartilage (meniscus).
Inﬂammation within the joint can lead to degradation of
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COX-2/PGE2-mediated upregulation of aggrecanase/
metalloproteinase activity [29,30]. Mild inﬂammation is
required for normal healing; however, excessive inﬂam-
mation may result in matrix breakdown rates greater than
repair rates [31]. Degradation of the cartilagematrix results
in the release of GAGs, and therefore, the concentration of
GAGs within the joint postexercise is an indication of the
rate and severity of matrix breakdown. In the present
study, the inﬂammatory response within the intercarpal
joint was negligible or mild at best, with respect to PGE2
and NO (Table 3). Although there was evidence for a
tendency to increased GAG release in the Control trial and
in the presupplementation test of the supplement trial, the
synovial ﬂuid GAG concentration tended to be lower after
supplementation than in the Control trial (Fig. 2). Further
research is required to conﬁrm or refute a beneﬁcial effect.
4.2. Systemic/Muscle Effects
In the context of high-intensity exercise, increases in the
plasma concentrations of enzymes/molecules present
within skeletal muscle cells including CK, creatine, AST,
alkaline phosphatase (Alk P), and gamma-glutamyl trans-
ferase are considered to be indicators of skeletal muscle
damage [32,33]. In the present study, each exercise test
resulted in mild-to-moderate muscle injury, as evidenced
by increases in plasma creatine and all four enzymes at
1-hour after exercise (Table 5). The oxidative stress
associated with intense exercise [3,4,34] can result in rapid
increase in ROS that oxidize and damage cell membrane
lipid components, with attendant loss of membrane
integrity and appearance of muscle-speciﬁc enzymes in the
blood [6,7,35]. During prolonged or strenuous exercise,
malonyldialdehyde (the main component of TBARS) is
strongly associated with increased circulating levels of
muscle-speciﬁc proteins such as CK [5,36,37]. The concen-
trations of these markers in plasma rise after cessation of
exercise, and the peak is proportional to the magnitude of
muscle injury [38].
In thepresent study, a signiﬁcant, systemic inﬂammatory
response was not evident. In the control trial, signiﬁcant
elevations for CK and AST persisted to 24 hours after exer-
cise; in contrast, after 23 days of the supplement, therewere
no signiﬁcant elevations, and there were no differences
between control trials and supplement trials. When plasma
markers of oxidative stress (Fig. 3) are examined after
23 days of the supplement, there was a tendency for
decreased TBARS postsupplementation at all time points,
suggesting decreased lipid peroxidation of cell membranes.
At the same time, TAS and SOD activity were both signiﬁ-
cantly increased; both of these would act to reduce the
oxidative stress present at affected tissue sites [1].
Other researchers have also investigated the hypothesis
that oral supplementation with SOD-rich products will
reduce the severity of oxidative stress and damage
associated with high-intensity exercise (reviewed by
Carillon et al. [39]). As noted by Carillon et al. [39] it is
highly unlikely that dietary SOD itself confers the observed
effects, as SOD is degraded within the intestinal tract. Notin
et al. [40] studied 2 groups of 12 Standardbreds in training,of which one group received an SOD-rich powdered melon
concentrate similar to that present in the supplement used
in this study. The trial group received the equivalent of 520
IU of SOD/day for 60 days, and the placebo group
received the excipient with no active substances. On days 0,
30, and 60 of supplementation, the physiological
responses to a standardized exercise test were assessed,
including plasma creatine kinase, erythrocyte SOD activity,
and blood resistance to hemolysis. In the “SOD” group,
60 days of supplementation resulted in a signiﬁcant
increase in the plasma resistance to hemolysis, and resting
plasma CK remained unchanged but increased in the
placebo group. The authors concluded that the melon-
concentrate supplement may make erythrocyte and
muscle cells membranes less permeable during the stresses
associated with regular exercise training. Lamprecht and
Williams [35] evaluated the effect of oral SOD-rich
melon-concentrate supplement on responses to intense,
exhaustive exercise in horses. Horses were fed the
equivalent of 3,000 IU SOD/day of powder for 6 weeks. The
authors reported no beneﬁt on blood and synovial ﬂuid
markers of inﬂammation (PGE2, chondroitin sulfate; gene
transcripts for interferon-gamma, interleukin-10, and
interleukin-1b in blood, and decreased plasma NO) and
antioxidant status (SOD activity, total glutathione,
glutathione peroxidase) in response to a single bout of
repeated sprint exercise test at 6 weeks.
The beneﬁts of dietary supplementation with the
speciﬁc aim to upregulate the concentrations and activities
of the enzymes capable of degrading ROS (SOD, catalase,
glutathione peroxidase) in horses performing exercise
remain unclear, with differences in dosage and outcomes.
The present study supplemented melon concentrate at the
equivalent of 2,600 IU SOD per horse per day but also
provided beta-glucans and other ingredients that may have
contributed to beneﬁcial effects. It is also unlikely that it is
not the exogenous SOD that is exerting the effects, but
rather that other compounds within the SOD-rich
melon concentrate is, either directly or indirectly,
responsible for inducing antioxidative effects [39].
Orally supplemented SOD-rich products are typically
encapsulated to protect against breakdown by gastric acids,
they have low bioavailability (14%–22%; [41]) and once in
the circulation are rapid elimination by the kidneys [39].
Encapsulated forms have been developed that are capable
of eliciting in mice in vivo, and cells in vitro, antioxidative
effects [42–44].
4.3. Limitations
The numbers of horses used in each group, and the
attrition within each group due to exercise and other
factors unrelated to the experiment, was a limiting factor.
The results prevent ﬁrm conclusions but provide the basis
for additional research. A possible limitation of the study,
given that ﬁve of the horses participated in both trials, is
that it is unknown whether 21 days of washout of the
supplement was an inadequate duration of time for
complete loss of effects of supplementation. However,
because ﬁve of the seven horses that completed the
supplement trial performed the control trial ﬁrst, no
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that washout duration for the two of seven horses that
performed the supplement trial ﬁrst was a factor that
inﬂuenced the results of this study. The exercise test
resulted in a hemoconcentration (increased plasma
proteins and PCV) that persisted to the ﬁrst hour after
exercise consistent with numerous exercise studies (see
[45,46] for reviews). The postexercise time points of 1 hour
and 24 hours were chosen based on the literature [47–49]
and on a pilot study that analyzed samples taken at 0.5, 1,
2, 4, 8, and 24 hours after exercise performed by us (M.I.L.,
J.M., and W.P., unpublished). These time points were
proximal to when peak effects occurred, and taking only
three samples in a 24-hour period minimized trauma and
risk of inﬂammation due to the repeated arthrocentesis
procedure [49].
4.4. Design of the Supplement
The supplement used in the present study was designed
to exert main effects by inﬂuencing oxidative stress,
inﬂammation, and immune function. In this section, we
point to putative mechanisms for the beneﬁts reported in
the present study. Among the main ingredients of the
supplement are an SOD-rich melon concentrate, yeast,
mushrooms, and omega-3 fatty acids. The SOD-rich melon
concentrate was selected based on reports of improved
antioxidant status [42,50,51]. As discussed above, the
results of supplementing SOD-rich melon concentrate to
horses has produced mixed results, with indications of
potential for increased oxidative status and reducing
inﬂammation. The omega-3 fatty acids were chosen for
their ability to reduce inﬂammation [52], although such
effects have not been reported in horses there appear to be
other health beneﬁts including improved blood fatty acid
proﬁle [53], improved oxidative balance after exercise [34],
and improved serum glucose:insulin ratios with lower
cholesterol [54]. The yeast and mushrooms contribute
beta-glucans which have immune-enhancing properties
[11,55]. Beta-glucans are a class of polysaccharides derived
from cell walls of yeast, fungi, algae, and oats. Horses
consuming oats and oat products as a normal part of their
diet will be receiving oat beta-glucans. Beta-glucans in
general, when supplemented to the diet, enhance immune
system functions via direct stimulation of macrophages,
neutrophils, and NK cells [55]. Beta-glucan supplementa-
tion has been associated with improved defense against
microbial challenges in vitro and in vivo [8,9,11], including
elite athletes during periods of strenuous training [56].
In vitro, increased concentrations of proinﬂammatory
monocytes and cytokines (IL-4, IL-5, and IFN-g) compared
to placebo [57] have led authors from the Davis group to
conclude that beta-glucans have the potential to alter
immune function after strenuous exercise.
5. Conclusions
In summary, 23 days of feeding horses a nutraceutical
supplement designed to combat oxidative stress, inﬂam-
mation, and enhance immune function provided some
support that supplementation attenuated increases inmuscle and joint markers of inﬂammation of oxidative
stress after high-intensity exercise in horses. There is
interplay between oxidative stress, inﬂammation, and
immune function that has important implications for how
and what we feed horses and when best to exercise train
and compete horses. A nutritional supplement that reduces
the oxidative stress associated with intense exercise should
reduce the amount of skeletal muscle damage that occurs,
with attendant reductions in inﬂammation and pain and
with improved postexercise recovery.Acknowledgments
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